Overall, these findings suggest that incorporating Pg-specific antigens into oral polymeric nanocarriers could be a promising approach to elicit both local and systemic immunity, potentially blocking Pg dissemination and the associated inflammatory response implicated in AD. This evidence concerns the gene JUP and Alzheimer disease.